BUFFALO, N.Y. — The Roswell Park Comprehensive Cancer Center out of Buffalo New York, is partnering with Cuba’s Havana’s Centre for Molecular Immunology (CIM) through an innovative lung cancer immunotherapy —CIMAvax-EGF— in a groundbreaking international collaboration with an immunotherapy developed in Cuba to treat lung cancer.

